&nbsp;

metis-brochure-thumbnail.jpg

Apr 2021

Document

metis-fr-brochure-thumbnail.jpg

May 2021

Regimen

MPV+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Drugs Used:

riTUXimab (Unfunded),

Quick Link(s):

Regimen Monograph

Jun 2022

Guidelines and Advice

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Status: Current
ID: GL 1-23-A

Jul 2021

Regimen

MFOLFOX6+NIVL

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Measuring Ontario’s Small Area Inequalities in Cancer (MOSAIC) Study

Document

MOSAIC_Placemat.pdf

Jan 2022

Document

mosaicPlacemat.jpg

Feb 2022

Guidelines and Advice

18F-FET PET Imaging in Brain Tumours

Status: Current
ID: ES PET 20

Apr 2022

Regimen

MFOLFOX6+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Drugs Used: